PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic ...

SAN JOSE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...

PROCEPT BioRobotics PRCT is gearing up to announce its quarterly earnings on Wednesday, 2025-08-06. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, ...

Procept BioRobotics Corporation is in the early stages of penetrating a massive $20B BPH surgery market with its innovative, recurring-revenue robotic systems. The company’s strong revenue and install ...

The next frontier in robotics will take inspiration from biology to design robots that are soft, smart, green and social. From microrobots for cancer treatment, to swarms powering warehouses, soft ...

Next Century Growth Investors, LLC, an investment Management Company, released its "Small Cap Strategy" second-quarter 2024 investor letter. A copy of the letter can be downloaded here. The equities ...

PROCEPT BioRobotics (PRCT) shares have been under pressure recently, sliding 15% over the past month and dropping 41% in the past 3 months. Investors may be weighing the company’s longer-term growth ...

BTIG Research reaffirmed their neutral rating on shares of PROCEPT BioRobotics (NASDAQ:PRCT – Free Report) in a report issued on Tuesday morning,Benzinga reports. A number of other equities analysts ...

SAN JOSE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...